Alan F. Denenberg

Davis Polk advised Shockwave Medical, Inc. on its SEC-registered public offering of 1,955,000 shares of common stock for an aggregate price to the public of approximately $89.4 million,…

Davis Polk advised Credo Technology Group Holding Ltd on its private placement of approximately $100 million in shares of its Series D preferred stock. Credo is a leading provider of high…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a follow-on offering of 4,025,000 shares of common stock of SiTime…

Davis Polk advised the representatives of the several underwriters in connection with the SEC-registered offering of 5,980,000 shares of common stock of ChemoCentryx, Inc. (which…

Davis Polk advised the initial purchasers on a Rule 144A offering by Jazz Investments I Limited, a wholly owned subsidiary of Jazz Pharmaceuticals plc, of $850 million aggregate…

Davis Polk advised the representatives of the several initial purchasers in connection with a Rule 144A offering by Palo Alto Networks, Inc. of an aggregate principal amount of $2…

Davis Polk advised the joint book-running managers on the SEC-registered offering by SVB Financial Group of $500 million aggregate principal amount of the company’s 3.125% senior notes…

Davis Polk advised the financial adviser to Microchip Technology Incorporated in connection with Microchip’s privately negotiated exchanges of $383.3 million aggregate principal amount…

Davis Polk advised the joint book-running managers in connection with a $10 billion SEC-registered debt offering by Amazon.com, Inc., consisting of $1 billion of its 0.400% notes due…

Davis Polk advised the sole bookrunner in connection with the SEC-registered offering of 2,500,000 shares of Class A common stock of Appian Corporation by Appian and certain existing…